{"result": "(\"entity\"<|>HEPARINA<|>ORGANIZATION<|>Heparin is an anticoagulant medication used to prolong catheter use and reduce complications related to catheter obstructions and sepsis episodes.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>ORGANIZATION<|>Nutritional support provided intravenously, prepared in a pharmacy to ensure asepsis and stability of components.)\n##\n(\"entity\"<|>VITAMINA D3<|>ORGANIZATION<|>Vitamin D3, also known as cholecalciferol, is a nutrient important for calcium absorption and bone health.)\n##\n(\"entity\"<|>VITAMINA K1<|>ORGANIZATION<|>Vitamin K1 is essential for blood clotting and bone metabolism.)\n##\n(\"entity\"<|>VITAMINA B12<|>ORGANIZATION<|>Vitamin B12, or cobalamin, is crucial for nerve function and the production of DNA and red blood cells.)\n##\n(\"entity\"<|>VITAMINA A<|>ORGANIZATION<|>Vitamin A is important for vision, immune function, and skin health.)\n##\n(\"entity\"<|>VITAMINA E<|>ORGANIZATION<|>Vitamin E is an antioxidant that helps protect cells from damage and is important for immune function.)\n##\n(\"entity\"<|>NUTRICIONES BINARIAS<|>ORGANIZATION<|>Binary nutrition refers to the administration of lipids separately from other nutrients in parenteral nutrition.)\n##\n(\"entity\"<|>NUTRICIONES TERNARIAS<|>ORGANIZATION<|>Ternary nutrition combines lipids, amino acids, and glucose in one solution for parenteral nutrition, reducing manipulation and contamination risk.)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>HEPARINA<|>Heparin is added to parenteral nutrition to enhance its effectiveness and reduce complications related to catheter use.<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>VITAMINA D3<|>Vitamin D3 is included in parenteral nutrition to support calcium absorption and overall health.<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>VITAMINA K1<|>Vitamin K1 is included in parenteral nutrition to ensure proper blood clotting and metabolic functions.<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>VITAMINA B12<|>Vitamin B12 is included in parenteral nutrition to support nerve function and red blood cell production.<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>VITAMINA A<|>Vitamin A is included in parenteral nutrition for its role in vision and immune function.<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>VITAMINA E<|>Vitamin E is included in parenteral nutrition for its antioxidant properties and immune support.<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>NUTRICIONES BINARIAS<|>Binary nutrition is a method of administering nutrients separately, which is a consideration in parenteral nutrition preparation.<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>NUTRICIONES TERNARIAS<|>Ternary nutrition is a preferred method in parenteral nutrition for its efficiency and reduced risk of contamination.<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: D3 (cholecalciferol) | 400 UI (10 mcgr) | 120 | | |\n| Tiamina (Vitamina B1) (como hidroclorida) | 1.2 mg | 0.36 | | |\n| Riboflavina (vitamina B2) (riboflavina 5-P-sódico) | 1.4mg | 0.54 | | |\n| Piridoxina HCL (Vitamina B6) | 1 mg | 0.3 | | |\n| Niacinamida | 17 mg | 5.1 | | |\n| Dexpanthenal (como d-pantothenyl acolhol) | 5 mg | 1.5 | | |\n| Vitamina E*.2 mgna K (d-alfa tocophenyl acetato)l)5-fosfato snte, con la siguiente composicixlucisva de m (d-alfa tocophenyl acetato) | 7 UI (7 mg) | 2,1 | | |\n| Vitamina K1* | 0.2 mg | 0.06 | | |\n| Acido Fólico | | | 140 microg | 54 |\n| Biotina | | | 20 microgr | 6 |\n| Vitamina B12 (cianocobalamina) | | | 1 microgr | 0,3 |\n\n*Polisorbato D añadido para solubilizar en agua las vitaminas liposolubles\n\nVitamina A 2.300 UI = 0,7 mg, Vitamina D3 400 UI = 10 micgrog, Vitamina E 7 UI = 7 mg\n---\n# HEPARINA\n\nSe añadirá 0,5 UI/ml de heparina a la parenteral por vía central por sus potenciales beneficios (prlongar el uso del catéter, disminuir las obstrucciones sin complicaciones añadidas y disminuir los episodios de sepsis relacionadas con catéter).\n\n## PREPARACIÓN, ESTABILIDAD, ADMINISTRACIÓN Y TIPOS DE NP.\n\n### PREPARACIÓN\n\nLa nutrición parenteral se prepara en farmacia diariamente, bajo campana de flujo laminar horizontal, lo que garantiza la adecuada asepsia durante la preparación, así como la estabilidad, compatibilidad y adecuación de los componentes prescritos.\n\nPara los ingresos fuera de horario de farmacia se dispone en nevera de unas preparaciones estándar con la siguiente composición:\n\n1. Nutrición parenteral estándar de inicio para vía periférica\n2. Nutrición parenteral estándar de inicio para vía central.\n\n### ESTABILIDAD Y PEROXIDACIÓN\n\nLa NP de los RN por su elevado contenido en Ca/P tiene elevado riesgo de precipitación calcio-fósforo. Para evitarla se utilizan sales orgánicas como el glicerofosfato cálcico. El ph de la mezcla influye en la solubilidad (el ph alcalino favorece la precipitación).\n\nMedidas encaminadas a disminuir la peroxidación son evitar el contacto con el oxígeno durante la preparación, el uso de bolsas multicapa para evitar el paso de oxígeno, la conservación en refrigeración, la fotoprotección y el uso de nutriciones ternarias o bolsas \"todo en uno\".\n\n### NUTRICIONES BINARIAS vs TERNARIAS\n\nHasta la fecha se han empleado nutriciones binarias, es decir, los lípidos se administran aparte. Las ternarias tienen las siguientes ventajas: menor manipulación, menor coste por precisar menos material de administración (una sola bomba y menos fungible), y menor riesgo de contaminación. En principio, siempre que se pueda garantizar la estabilidad, es la forma ideal de administración.\n\nLa adición de heparina es un factor adicional que contribuye a la desestabilización. Para evitar la desestabilización de la NP se establece un protocolo que incluye seguir un orden de adición de los componentes (siempre los aminoácidos primero) y vigilar la concentración final de aminoácidos (mayor de 2-2,5%), glucosa y lípidos.\n---\n## ADMINISTRACIÓN:\n\nLa nutrición parenteral durante el período neonatal se administra a lo largo de 24 horas, mediante bomba de infusión. La manipulación de las vías centrales ha de ser estéril.\n\nNo se deben administrar fármacos en Y sin que se haya demostrado su compatibilidad.\n\n## MONITORIZACIÓN Y COMPLICACIONES:\n\nLas pautas de monitorización son orientativas, dependerá de la situación clínica de cada paciente.\n\nFase inicial (primera semana): glucosa, electrolitos, gasometría, bun diarios hasta llegar al aporte ideal de NP. Calcio, fósforo, magnesio, triglicéridos, 2 veces por semana.\n\nFase estable (> 1 semana): glucosa, electrolitos, gasometría cada 2-3 días.\nCa, P, Mg, Fa, albúmina, creatinina, triglicéridos cada 15 días.\nCu, Zc, vitaminas: 1\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}